US Wall St 30
Short
Updated

US30 Bearish Momentum | Key Support Levels in Focus

676
US30 Analysis | February 21, 2025
The price has broken below the pivot line of 44,404, confirming a bearish momentum. Now, it is testing the support zone at 44,051, and a continued failure to reclaim the pivot will strengthen the bearish case toward 43,763 and 43,212 support zones.

For bullish confirmation, the price needs to stabilize above 44,404 and break the resistance zone of 44,500 to initiate a potential recovery toward 44,756 and 45,099.

Key Levels:
Pivot Line: 44075
Resistance Levels: 44190 – 44404 – 44650
Support Levels: 43763 – 43520 - 43212

📉 Directional Bias: As long as the price remains below 44,404, US30 remains bearish, with a high probability of testing lower support levels.
Trade active
US30
Update

Moving Well +300 pip ✅

The Dow Jones remains under bearish pressure, but it must break below 43,760 to confirm the next bearish targets at 43,570 and 43,250.

Bearish Scenario: A break below 43,760 → Targets 43,570 & 43,250
Bullish Volatility: If the price stabilizes above 43,890, it may fluctuate between 43,760 and 43,995

Timeframe 4h, 1h
current price 43760

snapshot
Trade closed: target reached
US30 Analysis Update: 750-Pip Drop as Expected

The bearish momentum played out as anticipated, with price breaking below key pivot and support levels. Our analysis highlighted the weakness around 43,763, leading to a clean drop toward the third support target at 42,769, delivering a 750-pip decline.

Key Observations:

✅ Price respected the pivot rejection and failed to regain bullish momentum.
✅ The support zone at 43,212 provided a brief reaction before the continuation drop.
✅ The final target of 42,769 - 42,588 was successfully reached, confirming bearish strength.

With the target reached, we are now observing price action for potential new setups. If support holds, we may see a retracement or even a shift in momentum. However, continued weakness could drive further downside below 42,500.

snapshot

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.